Profile
Full Name
Inozyme Pharma, Inc.Ticker Symbol
INZYExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
July 24, 2020Indexes
Not includedWebsite
http://www.inozyme.comEmployees
67Key Details
Price
$0.95(-1.33%)
Market cap
$60.98M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$1.62(-18.25% YoY)
PE ratio
-
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Inozyme Pharma doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 10, 25 HC Wainwright & Co.
BuyApr 8, 25 Needham
BuyMar 12, 25 Raymond James
OutperformMar 11, 25 Piper Sandler
OverweightMar 11, 25 Needham
BuyMar 11, 25 HC Wainwright & Co.
BuyJan 13, 25 Wells Fargo
OverweightJan 13, 25 Piper Sandler
OverweightJan 13, 25 HC Wainwright & Co.
BuyJan 10, 25 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Inozyme Pharma?
- Does Inozyme Pharma pay dividends?
- What sector is Inozyme Pharma in?
- What industry is Inozyme Pharma in?
- What country is Inozyme Pharma based in?
- When did Inozyme Pharma go public?
- Is Inozyme Pharma in the S&P 500?
- Is Inozyme Pharma in the NASDAQ 100?
- Is Inozyme Pharma in the Dow Jones?
- When was Inozyme Pharma's last earnings report?
- When does Inozyme Pharma report earnings?
- Should I buy Inozyme Pharma stock now?
What is the ticker symbol for Inozyme Pharma?
The ticker symbol for Inozyme Pharma is NASDAQ:INZY
Does Inozyme Pharma pay dividends?
No, Inozyme Pharma does not pay dividends
What sector is Inozyme Pharma in?
Inozyme Pharma is in the Healthcare sector
What industry is Inozyme Pharma in?
Inozyme Pharma is in the Biotechnology industry
What country is Inozyme Pharma based in?
Inozyme Pharma is headquartered in United States
When did Inozyme Pharma go public?
Inozyme Pharma's initial public offering (IPO) was on July 24, 2020
Is Inozyme Pharma in the S&P 500?
No, Inozyme Pharma is not included in the S&P 500 index
Is Inozyme Pharma in the NASDAQ 100?
No, Inozyme Pharma is not included in the NASDAQ 100 index
Is Inozyme Pharma in the Dow Jones?
No, Inozyme Pharma is not included in the Dow Jones index
When was Inozyme Pharma's last earnings report?
Inozyme Pharma's most recent earnings report was on Mar 10, 2025
When does Inozyme Pharma report earnings?
The next expected earnings date for Inozyme Pharma is May 7, 2025
Should I buy Inozyme Pharma stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions